Buscar
Translational Development Acquisition Corp
TDACAñadir a la lista de seguimiento
10.860USD
-0.020-0.18%
Cierre 09-24 16:00（ET）
209.71MCap. mercado
38.33P/E TTM
Acerca de Translational Development Acquisition Corp Compañía
Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.
Perfil de Translational Development Acquisition Corp
Símbolo de cotizaciónTDAC
Nombre de la empresaTranslational Development Acquisition Corp
Fecha de salida a bolsaDec 23, 2024
Director ejecutivoHoffman (Michael B)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 23
Dirección52 E 83Rd St.
CiudadNEW YORK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal10028
Teléfono14132042769
Sitio Web
Símbolo de cotizaciónTDAC
Fecha de salida a bolsaDec 23, 2024
Director ejecutivoHoffman (Michael B)
Ejecutivos de Translational Development Acquisition Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Translational Development Acquisition Corp?
Los cinco principales accionistas de Translational Development Acquisition Corp son: Mr. Michael B. Hoffman
¿Cuántas instituciones poseen acciones de Translational Development Acquisition Corp (TDAC)?
A fecha de 2026Q1, 54 instituciones poseen acciones de Translational Development Acquisition Corp, con un valor de mercado combinado de aproximadamente 17.02M, lo que representa el 98.67% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -375852.00.